AAAAAA

   
Results: 1-18 |
Results: 18
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertensionand neointimal formation in rats
Authors: Nishimura, T Faul, JL Berry, GI Veve, I Pearl, RG Kao, PN
Citation: T. Nishimura et al., 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertensionand neointimal formation in rats, AM J R CRIT, 163(2), 2001, pp. 498-502
Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness
Authors: Rodriquez, RM Corwin, HL Gettinger, A Corwin, MJ Gubler, D Pearl, RG
Citation: Rm. Rodriquez et al., Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness, J CRIT CARE, 16(1), 2001, pp. 36-41
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial (Reprinted from Critical Care Medicine, vol 27, pg 2346-2350, 1999)
Authors: Corwin, HL Gettinger, A Rodriguez, RM Pearl, RG Gubler, KD Enny, C Colton, T Corwin, MJ
Citation: Hl. Corwin et al., Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial (Reprinted from Critical Care Medicine, vol 27, pg 2346-2350, 1999), CRIT CARE M, 29(9), 2001, pp. S201-S205
Sonic vibrational analysis provides continuous measurement of arterial properties
Authors: Rodriguez, RM Sher, MH Beringer, KA Caro, RG Pearl, RG
Citation: Rm. Rodriguez et al., Sonic vibrational analysis provides continuous measurement of arterial properties, J CLIN M C, 16(7), 2000, pp. 501-508
Inhaled nitric oxide and pulmonary vasoreactivity
Authors: Aranda, M Pearl, RG
Citation: M. Aranda et Rg. Pearl, Inhaled nitric oxide and pulmonary vasoreactivity, J CLIN M C, 16(5-6), 2000, pp. 393-401
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats
Authors: Faul, JL Nishimura, T Berry, GJ Benson, GV Pearl, RG Kao, PN
Citation: Jl. Faul et al., Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats, AM J R CRIT, 162(6), 2000, pp. 2252-2258
Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit
Authors: Bradford, KK Deb, B Pearl, RG
Citation: Kk. Bradford et al., Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit, J CARDIO PH, 36(2), 2000, pp. 146-151
Nimodipine-induced acute hypoxemia: Case report - Comment
Authors: Pearl, RG Steinberg, GK
Citation: Rg. Pearl et Gk. Steinberg, Nimodipine-induced acute hypoxemia: Case report - Comment, NEUROSURGER, 47(5), 2000, pp. 1247-1247
Prolonged mechanical ventilation after cardiac surgery: Diagnosis of a better prognosis
Authors: Pearl, RG
Citation: Rg. Pearl, Prolonged mechanical ventilation after cardiac surgery: Diagnosis of a better prognosis, CRIT CARE M, 28(8), 2000, pp. 3094-3096
Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxicpulmonary hypertension
Authors: Nagamine, J Hill, LL Pearl, RG
Citation: J. Nagamine et al., Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxicpulmonary hypertension, CRIT CARE M, 28(7), 2000, pp. 2420-2424
Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension
Authors: Deb, B Bradford, K Pearl, RG
Citation: B. Deb et al., Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension, CRIT CARE M, 28(3), 2000, pp. 795-799
Flow triggering, pressure triggering, and autotriggering during mechanicalventilation
Authors: Hill, LL Pearl, RG
Citation: Ll. Hill et Rg. Pearl, Flow triggering, pressure triggering, and autotriggering during mechanicalventilation, CRIT CARE M, 28(2), 2000, pp. 579-581
Combined inhaled nitric oxide and inhaled prostacyclin during experimentalchronic pulmonary hypertension
Authors: Hill, LL Pearl, RG
Citation: Ll. Hill et Rg. Pearl, Combined inhaled nitric oxide and inhaled prostacyclin during experimentalchronic pulmonary hypertension, J APP PHYSL, 86(4), 1999, pp. 1160-1164
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
Authors: Corwin, HL Gettinger, A Rodriguez, RM Pearl, RG Gubler, KD Enny, G Colton, T Corwin, MJ
Citation: Hl. Corwin et al., Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial, CRIT CARE M, 27(11), 1999, pp. 2346-2350
Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension
Authors: Patterson, KW Deb, B Kavanagh, BP Pearl, RG
Citation: Kw. Patterson et al., Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension, PHARMACOL, 58(5), 1999, pp. 246-251
Inhibition of endogenous nitric oxide synthesis potentiates the effects ofsodium nitroprusside but not of adenosine in experimental pulmonary hypertension
Authors: Wall, MH Patterson, KW Kavanagh, BP Pearl, RG
Citation: Mh. Wall et al., Inhibition of endogenous nitric oxide synthesis potentiates the effects ofsodium nitroprusside but not of adenosine in experimental pulmonary hypertension, PHARMACOL, 58(1), 1999, pp. 34-43
Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension
Authors: Aranda, M Bradford, KK Pearl, RG
Citation: M. Aranda et al., Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension, ANESTH ANAL, 89(1), 1999, pp. 152-158
Continuous cardiac output catheters - Delay in in vitro response time after controlled flow changes
Authors: Aranda, M Mihm, FG Garrett, S Mihm, MN Pearl, RG
Citation: M. Aranda et al., Continuous cardiac output catheters - Delay in in vitro response time after controlled flow changes, ANESTHESIOL, 89(6), 1998, pp. 1592-1595
Risultati: 1-18 |